Completed NA NCT06130462
Detection of Aluminium-reactive T-lymphocytes in Patients With Vaccination Granulomas
Sponsor: National Allergy Research Center, Denmark
Conditions
Aluminum Allergy Granuloma
Interventions
Aluminum Tetanus toxoid
Updated 3 times since 2023 Last updated: Nov 8, 2023 Started: Sep 13, 2022 Primary completion: Oct 24, 2022 Completion: Feb 20, 2023
A NA clinical study on Aluminum Allergy and Granuloma, this trial is completed. The trial is conducted by National Allergy Research Center, Denmark and has accumulated 3 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Change History
3 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Dec 2023 — Jul 2024 [monthly]
Completed NA
First recorded
Sep 2022
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- National Allergy Research Center, Denmark
Data source: National Allergy Research Center, Denmark
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Hellerup, Denmark